Docetaxel and Flavopiridol in Treating Patients With Refractory Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
Drugs used in chemotherapy, such as docetaxel and flavopiridol, work in different ways to
stop the growth of tumor cells, either by killing the cells or by stopping them from
dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
Flavopiridol may also help docetaxel work better by making tumor cells more sensitive to the
drug. This phase II trial is studying how well giving docetaxel followed by flavopiridol
works in treating patients with refractory metastatic pancreatic cancer.